This content is in French.
Improving the efficacy of cancer immunotherapy
13 février 2024
The efficacy of anti-cancer treatments, including immunotherapy, is limited by chronic tumorigenesis induced by inflammation and toxicity of the tumor microenvironment. By reducing inflammation in the tumor microenvironment, it may be possible to enhance the activity…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Abigail G Kelly et al. Enhancing cancer immunotherapy via inhibition of soluble epoxide hydrolase. Proc Natl Acad Sci U S A. 2024 Feb 13;121(7):e2314085121.
View the source
